Nephrectomy for kidney tumour increases the risk of de novo arterial hypertension

Author:

Bigot Pierre1ORCID,Bernhard Jean‐Christophe2,Khene Zine‐Eddine3ORCID,Dariane Charles4,Lebdai Souhil1,Doumerc Nicolas5,Nouhaud François Xavier6,Ouzaid Idir7,Saulnier Patrick8,Méjean Arnaud4,Roupret Morgan9,Bensalah Karim3,

Affiliation:

1. Department of Urology Angers University Hospital Angers France

2. Department of Urology Bordeaux University Hospital Bordeaux France

3. Department of Urology Rennes University Hospital Rennes France

4. Department of Urology, Hôpital Européen Georges‐Pompidou Paris France

5. Department of Urology, CHU de Toulouse Toulouse France

6. Department of Urology Rouen University Hospital Rouen France

7. Department of Urology Angers University Hospital Paris France

8. Department of Biostatistics Angers University Hospital Angers France

9. Department of Urology, Hôpital Pitié‐Salpêtrière Sorbonne Université Paris France

Abstract

ObjectiveTo evaluate prospectively the effects of surgical excision of renal tumours on blood pressure (BP).Patients and MethodsIn a multicentre prospective study, we evaluated 200 patients who underwent nephrectomy for renal tumour between 2018 and 2020 at seven departments of the French Network for Kidney Cancer, the UroCCR. All patients had localized cancer without pre‐existing hypertension (HTN). Blood pressure was measured the week before nephrectomy, and at 1 month and 6 months after nephrectomy, according to the recommendations for home BP monitoring. Plasma renin was measured 1 week before surgery and 6 months after surgery. The primary endpoint was the occurrence of de novo HTN. The secondary endpoint was clinically significant increase in BP at 6 months, defined by an increase in systolic and/or diastolic ambulatory BP ≥10 mmHg or requirement for medical antihypertensive treatment.ResultsBlood pressure and renin measurements were available for 182 (91%) and 136 patients (68%), respectively. We excluded from the analysis 18 patients who had undeclared HTN detected on preoperative measurements. At 6 months, 31 patients (19.2%) had de novo HTN and 43 patients (26.3%) had a significant increase in their BP. Type of surgery was not associated with an increased risk of HTN (21.7% partial nephrectomy [PN] vs 15.7% radical nephrectomy [RN]; P = 0.59). There was no difference between plasmatic renin levels before and after surgery (18.5 vs 16; P = 0.46). In multivariable analysis, age (odds ratio [OR] 1.07, 95% confidence interval [CI] 1.02–1.12; P = 0.03) and body mass index (OR 1.14, 95% CI 1.03–1.26; P = 0.01) were the only predictors of de novo HTN.ConclusionSurgical treatment of renal tumours is associated with significant changes in BP, with de novo HTN occurring in almost 20% of the patients. These changes are not impacted by the type of surgery (PN vs RN). Patients who are scheduled to undergo kidney cancer surgery should be informed of these findings and have their BP closely monitored after the operation.

Funder

Association Française d'Urologie

Publisher

Wiley

Subject

Urology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Round up;Indian Journal of Urology;2023-12-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3